$POET

Summary

SIVE undervalued at <$2B MC; should be $4-6B private; NASDAQ catalyst near; CPO ramp 2027 drives 10x optical TAM

Reasoning

Ayar/Jabil primary supply lock, multiple transceiver qualifications, Goldman Sachs $141B optical TAM, NASDAQ listing premium catalyst, IP acquisition optionality

-> IP acquisition -> Just waiting for CPO to take off $SIVE is a laser chokepoint for photonics and are publicly validated by: - $GFS (1 of 2 public laser suppliers with $LITE for CPO per presentation) - $JBL (“Relatively dramatic moat” for pluggables built with Sivers) - CHIPS ACT for the overall company For highest visibility: -> Ayar is the largest CPO player that primary sources $SIVE and are expected to ramp in 2027. -> $POET is another near term CPO volume player that’s heavily visible with Sivers. For OSINT mapping: $MRVL Celestial (direct, not through Poet), Lightmatter, Lightelligence, were all high confidence customers of Sivers. $SIVE is also developing/qualifying with multiple more optical transceiver players following Jabil. It feels like they’re going to end up everywhere. I’m not sure people realize how special that many qualifications is coming from a <$2B MC laser company is… right before 2027 volume ramp. Especially while all the other laser companies trade at $15B-$70B valuations. Just need pluggables to bridge revenue gap into H2 2027 (CPO Scale up) Then making every laser they sell more valuable following the $LITE playbook, to capture more TAM of both markets. - In the overarching optical $141B TAM (10x) in the next 1 1/2 years. (Goldman Sachs) - and CPO TAM going from 0 to $81B in the next 1 1/2 years. So, easily multiply revenue opportunity overnight doing IP acquisition downstream. It’s more of just a waiting game, I think $SIVE is very undervalued relative to forward revenue potential. If it were a private Silicon Valley startup it would probably be worth $4-6B today. Just needs to get listed on NASDAQ for premiums to bridge that gap.

Return by horizon